These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 13609995)

  • 1. [Clinicostatistical study on 308 cases of Morgagni-Laennec liver cirrhosis].
    NICROSINI F
    G Clin Med; 1958 Aug; 39(8):1171-204. PubMed ID: 13609995
    [No Abstract]   [Full Text] [Related]  

  • 2. [Morgagni-Laennec cirrhosis; clinicostatistical study of 137 cases].
    LUSIANI GB; SALVI A
    Omnia Ther Suppl; 1955; 33(3-4):129-74. PubMed ID: 13289007
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinicostatistical observations on 161 cases of Morgagni-Läennec cirrhosis].
    PICCHIO E
    Policlinico Med; 1957; 64(2):100-12. PubMed ID: 13452874
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on liver cirrhosis. III. Megaloblastic anemia during Morgagni-Laennec cirrhosis].
    FALZOI M; MAGNANI B
    Prog Med (Napoli); 1953 Aug; 9(16):494-501. PubMed ID: 13112283
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anatomico-clinical studies of combined Morgagni-Laennec liver cirrhosis and malignant tumors].
    CARINCI MP
    Riv Gastroenterol; 1956; 8(6):173-85. PubMed ID: 13421470
    [No Abstract]   [Full Text] [Related]  

  • 6. [Association of a synthetic anabolizer, 4-chlorotestosterone acetate, with prednisone in the treatment of ascitogenic Morgagni-Laennec liver cirrhosis].
    BISARO A; CASASOLA M; MILESI C; GENERO RE
    Minerva Med; 1959 Feb; 50(13):449-59. PubMed ID: 13643875
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anatomical alterations of intrahepatic blood vessels in Morgagni-Laennec cirrhosis].
    MONTAGNANI CA; PACI G
    Boll Soc Ital Biol Sper; 1952 Jul; 28(7):1439-41. PubMed ID: 13018806
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemoglobin metabolism in Morgagni-Laennec cirrhosis].
    LATTANZI A
    Riv Gastroenterol; 1950; 2(5):241-67. PubMed ID: 14817009
    [No Abstract]   [Full Text] [Related]  

  • 9. [Previous jaundice in Morgagni-Läennec liver cirrhosis].
    GALLO V
    Minerva Med; 1948 Nov; 39(46 Pt 2):519-23. PubMed ID: 18104958
    [No Abstract]   [Full Text] [Related]  

  • 10. [New etiopathogenetic concepts and modern therapy of Morgagni-Laënnec liver cirrhosis].
    CAMPANA C
    Policlinico Prat; 1949 Jan; 56(4):97-111. PubMed ID: 18109675
    [No Abstract]   [Full Text] [Related]  

  • 11. Liver function test; clinicostatistical study of 189 cases of acute and chronic diffuse liver diseases. I. Serum bilirubin; fasting venous glycemia.
    MOSCHINI-ANTINORI E; GALLINA A
    Policlinico Med; 1954; 61(1):54-60. PubMed ID: 14371020
    [No Abstract]   [Full Text] [Related]  

  • 12. [Case of infantile cirrhosis of Laennec type].
    OLIVER-PASCUAL E; SANZ IBANEZ J; ANDOLZ F; ELOSEGUI C; FERNANDEZBASABE E; OLIVER A; PURAS E
    Rev Esp Enferm Apar Dig Nutr; 1958 Dec; 17(10):1095-107. PubMed ID: 13634549
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fever in Morgagni-Laennec cirrhosis: contribution in clinical statistics].
    BASTAGLI D; ORLANDI G
    G Clin Med; 1949 Sep; 30(9):726-42. PubMed ID: 15394662
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cancer antigen 125 as a marker of ascites in patients with liver cirrhosis].
    Jabłkowski M; Białkowska J; Koktysz R; Bartkowiak J; Stankiewicz W; Dworniak D
    Pol Merkur Lekarski; 2004; 17 Suppl 1():149-52. PubMed ID: 15603376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of tuberculosis in patients with liver cirrhosis.
    Cho YJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
    Respirology; 2007 May; 12(3):401-5. PubMed ID: 17539845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term prognosis of community-acquired bacteremia in patients with liver cirrhosis or alcoholism: A population-based cohort study.
    Linderoth G; Jepsen P; Schønheyder HC; Johnsen SP; Sørensen HT
    Alcohol Clin Exp Res; 2006 Apr; 30(4):636-41. PubMed ID: 16573581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cirrhosis after orthotopic liver transplantation in the absence of primary disease recurrence.
    Seyam M; Neuberger JM; Gunson BK; Hübscher SG
    Liver Transpl; 2007 Jul; 13(7):966-74. PubMed ID: 17370332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological and clinical aspects of liver cirrhosis in adult patients living in Southeastern Anatolia: leading role of HBV in 505 cases.
    Bayan K; Yilmaz S; Tuzun Y; Yildirim Y
    Hepatogastroenterology; 2007 Dec; 54(80):2198-202. PubMed ID: 18265632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
    Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
    Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol-related cirrhosis--early abstinence is a key factor in prognosis, even in the most severe cases.
    Verrill C; Markham H; Templeton A; Carr NJ; Sheron N
    Addiction; 2009 May; 104(5):768-74. PubMed ID: 19344445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.